On 3 October 2011 European Centre for Disease Prevention and Control (ECDC) and representatives of the European Vaccine Manufacturers  met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of seasonal and pandemic influenza. ECDC Director Marc Sprenger opened the meeting and ECDC influenza experts held different presentations, such as burden of influenza disease in the EU, risk groups for severe influenza disease, personal protective measures, pandemic influenza preparedness, seasonal influenza vaccines, communication.
The Declarations of Interest for ECDC Influenza Staff and the ECDC Director are available here under ECDC Transparency.

ECDC has organised the “Influenza Workshop Week” to support Member States and the European Commission in implementing the 2009 EU Council Recommendation on Seasonal Influenza Immunisation.

The workshop focused on seasonal influenza vaccination in the EU and the December 2009 Council Recommendations on this subject.

ECDC organised a workshop aimed at the Member States not participating in the ECDC Vaccine safety network.

February 2013, European Centre for Disease Prevention and Control (ECDC) and representatives of Vaccines Europe met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of influenza. ​

​Influenza vaccine effectiveness - annual meeting of the I-MOVE network with international guests from Canada, US, and the WHO.

The workshop aimed to explore new and more effective ways to promote influenza vaccination in healthcare professionals.

The objective for this meeting between ECDC and influenza vaccine manufacturers was to share latest information on influenza disease monitoring including severe disease, monitoring of seasonal influenza vaccination programmes in the EU and new technical developments for improved influenza vaccines.

Professor Mike Catchpole, Chief Scientist of ECDC, presented to the Environment, Public Health and Food Safety Committee of the European Parliament during an exchange of views on vaccination.

​This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.